Structure and function of lipopolysaccharides

Microbes and Infection

Volumn 4, Issue 8, 2002, Pages 837-851

  Erridge, Clett ^a   Bennett Guerrero, Elliott ^b   Poxton, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Endotoxins; Lipopolysaccharides; Molecular structure

Indexed keywords

BACTERIODES FRAGILIS LIPOPOLYSACCHARIDE; BACTERIUM LIPOPOLYSACCHARIDE; BORDETELLA PERTUSSIS LIPOPOLYSACCHARIDE; CAMPYLOBACTER JEJUNI LIPOPOLYSACCHARIDE; CARBOHYDRATE DERIVATIVE; CD14 ANTIGEN; CHLAMYDIA TRACHOMATIS LIPOLYSACCHARIDE; CORE POLYSACCHARIDE; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HELICOBACTER PYLORI LIPOPOLYSACCHARIDE; HEMOPHILUS INFLUENZAE LIPOPOLYSACCHARIDE; KLEBSIELLA PNEUMONIAE LIPOPOLYSACCHARIDE; LIPID A; LIPID A DERIVATIVE; NEISSERIA GONORRHEA LIPOPOLYSACCHARIDE; NEISSERIA MENINGITIDIS LIPOPOLYSACCHARIDE; O POLYSACCHARIDE; POLYSACCHARIDE; PSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDE; SALMONELLA MINNESOTA LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; YERSINIA PESTIS LIPOPOLYSACCHARIDE;

BACTEREMIA; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CHRONIC GASTRITIS; GASTROENTERITIS; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; IMMUNOPATHOLOGY; INTESTINE INFECTION; NONHUMAN; PERTUSSIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ANTIGENS, CD14; CARBOHYDRATE CONFORMATION; GRAM-NEGATIVE BACTERIA; LIPID A; LIPOPOLYSACCHARIDES;

MAMMALIA; NEGIBACTERIA;

EID: 0036629937     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01604-0     Document Type: Review

References (82)

1. Opal S.M., Scannon P.J., Vincent J.L., White M., Carroll S.F., Palardy J.E., Parejo N.A., Pribble J.P., Lemke J.H. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180:1999;1584-1589.
2. Martinez-Pellus A.E., Merino P., Bru M., Conejero R., Seller G., Munoz C., Fuentes T., Gonzalez G., Alvarez B. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit. Care. M. 21:1993;1684-1691.
3. Tanamoto K., Zahringer U., Mckenzie G.R., Galanos C., Rietschel E.T., Luderitz O., Kusumoto S., Shiba T. Biological activities of synthetic lipid A analogues: pyrogenicity, lethal toxicity, anticomplement activity and induction of gelation of limulus amoebocyte lysate. Infect. Immun. 44:1984;421-426.
4. Joiner K.A., Grossman N., Schmetz M., Leive L. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J. Immunol. 136:1986;710-715.
5. Joiner K.A., Schmetz M.A., Goldman R.C., Leive L., Frank M.M. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infect. Immun. 45:1984;113-117.
6. Rietschel E.T., Kirikae T., Schade F.U., Ulmer A.J., Holst O., Brade H., Schmidt G., Mamat U., Grimmecke H.D., Kusumoto S., Zahringer U. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology. 187:1993;169-190.
7. +: description of a novel deep rough mutant. Eur. J. Biochem. 177:1988;483-492.
8. Brade H., Brade L., Nano F.E. Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. PNAS. 84:1987;2508-2512.
9. Hammond S.M., Claesson A., Jansson A.M., Larsson L.G., Pring B.G., Town C.M., Ekstrom B. A new class of synthetic anti-bacterials acting on lipopolysaccharide biosynthesis. Nature. 327:1987;730-732.
10. Venezia N.D., Minka S., Bruneteau M., Mayer H., Michel G. Lipopolysaccharides from Yersinia pestis. Eur. J. Biochem. 151:1985;399-404.
11. Rietschel E.T., Kirikae T., Schade U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zahringer U., Seydel U., Di Padova F., Schreier M., Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:1994;217-225.
12. Bennett-Guerrero E., McIntosh T.J., Barclay G.R., Snyder D.S., Gibbs R.J., Mythen M.G., Poxton I.R. Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine. Infect. Immun. 68:2000;6202-6208.
13. Di Padova F., Brade H., Barclay G.R., Poxton I.R., Liehl E., Schuetze E., Kocher H.P., Ramsay G., Schreier M.H., McLelland D.B.L., Rietschel E.T. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect. Immun. 61:1993;3863-3872.
14. Galanos C., Luderitz O., Rietschel E.T., Westphal O., Brade H., Brade L., Freudenberg M., Schade U., Imoto M., Yoshimura H. Synthetic and natural E. coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148:1985;1-5.
15. Moran A.P. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. Rev. Infect. Dis. 176:(Suppl. 2):1997;S115-121.
16. Takada H., Kotani S. Morrison D.C., Ryan J.L., Bacterial Endotoxic Lipopolysaccharides. Vol. I. Molecular Biochemistry and Cellular Biology. 1992;107-131 CRC Press, Boca Raton, USA.
17. Rietschel E.T., Brade H., Brade L., Brandenburg K., Schade F.U., Seydel U., Zahringer U., Galanos C., Luderitz O., Westphal O., Labischinski H., Kusumoto S., Shiba T. Lipid A, the endotoxic centre of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog. Clin. Biol. Res. 231:1987;25-34.
18. Ulmer A.J., Heine H., Feist W., Kusumoto S., Kusama T., Brade H., Schade F.U., Rietschel E.T., Flad H.D. Biological activity of synthetic phosphono-oxyethyl analogues of lipid A and lipid A partial structures. Infect. Immun. 60:1992;3309-3314.
19. Aschauer I., Grob A., Hildebrandt J., Schutze E., Stutz P. Highly purified lipid X is devoid of immunostimulatory activity. Isolation and characterisation of immunostimulating contaminants in a batch of synthetic lipid X. J. Biol. Chem. 265:1990;9159-9164.
20. Erwin A.L., Munford R.S. Morrison D.C., Ryan J.L., Bacterial Endotoxic Lipopolysaccharides. Vol. I. Molecular Biochemistry and Cellular Biology. 1992;405-430 CRC Press, Boca Raton, USA.
21. Magnuson D.K., Weintraub A., Pohlmann H.T., Maier R.V. Human endothelial cell adhesiveness for neutrophils, induced by E. coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J. Immunol. 143:1989;3025-3030.
22. Delahooke D., Barclay G., Poxton I. TNF-α induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species. Infect. Immun. 63:1996;840-846.
23. Seydel U., Labischinski H., Kastowsky M., Brandenburg K. Phase behaviour, supramolecular structure and molecular conformation of lipopolysaccharide. Immunobiology. 187:1993;191-211.
24. Din Z.Z., Mukerjee P., Kastowsky M., Takayama K. Effect on solubility and ionic state of lipopolysaccharide obtained from the deep rough mutant of E. coli. Biochemistry. 32:1993;4579-4586.
25. Nowotny A., Spitzer J.J., Ziegler E.J., Cellular and Molecular Aspects of Endotoxin Reactions. 1990;Excerpta Medica, Amsterdam.
26. Akashi S., Ogata H., Kirikae F., Kawasaki K., Nishijima M., Shimazu R., Nagai Y., Fukudome K., Kimoto M., Miyake K. Regulatory roles for CD14 and phosphatidylinositol in the signalling via Toll-like receptor 4 - MD-2. Biochem. Biophys. Res. Commun. 268:2000;172-177.
27. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., Malo D. Endotoxin-tolerant mice have mutations in Toll like receptor 4 (. Tlr4). J. Exp. M. 189:1999;615-625.
28. Poltorak A., Xialong H., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signalling in C3H/HEJ and C57Bl/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
29. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Toll like receptor 4 deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR-4 as the lps gene product. J. Immunol. 162:1999;3749-3752.
30. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. M. 189:1999;1777-1782.
31. Hirschfield M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signalling through both human and murine toll-like receptor 2. J. Immunol. 165:2000;618-622.
32. Hirschfield M., Weis J.J., Toschchakov V., Salkowski C.A., Cody M.J., Ward D.C., Quereshi N., Michalek S.M., Vogel S.N. Signalling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:2001;1477-1482.
33. Werts C., Tapping R.I., Mathison J.C., Chuang T.H., Kravchenko V., Saint Girons I., Haake D.A., Godowski P.J., Hayashi F., Ozinsky A., Underhill D.M., Kirschning C.J., Wagner H., Aderem A., Tobias P.S., Ulevitch R.J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:2001;346-352.
34. Rosen G., Sela M.N., Naor R., Halabi A., Barak V., Shapira L. Activation of murine macrophages by lipoprotein and lipopolysaccharide of Treponema denticola. Infect. Immun. 67:1999;1180-1186.
35. Hailman E., Lichenstein H.S., Wurfel M.M., Miller D.S., Johnson D.A., Kelley M., Busse L.A., Zukowski M.M., Wright S.D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. M. 179:1994;269-277.
36. Wurfel M.W., Wright S. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers. J. Immunol. 158:1997;3925-3934.
37. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR-4 and MD-2. J. Biol. Chem. 276:2001;21129-21135.
38. Vasselon T., Hailman E., Thieringer R., Dietmers P.A. Internalisation of monomeric lipopolysaccharide occurs after transfer out of cell surface CD14. J. Exp. M. 190:1999;509-522.
39. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:2000;497-504.
40. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. PNAS. 97:2000;2163-2167.
41. Akashi S., Nagai Y., Ogata H., Oikawa M., Fukase K., Kusumoto S., Kawasaki K., Nishijima M., Hayashi S., Kimoto M., Miyake K. Human MD-2 confers on mouse Toll-like receptor 4 species specific lipopolysaccharide recognition. Int. Immunol. 13:2001;1595-1599.
42. Kawasaki K., Gomi K., Nishijima M. Gln22 of mouse MD-2 is essential for lipopolysaccharide mimetic action of Taxol. J. Immunol. 166:2001;11-14.
43. Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K., Nishijima M. Mouse Toll like receptor 4. MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J. Biol. Chem. 275:2000;2251-2254.
44. Medzhitov R., Preston-Hurlburt P., Janeway Jr C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
45. Viriyakosul S., Tobias P.S., Kitchens R.L., Kirkland T.L. MD-2 binds to lipopolysaccharide. J. Biol. Chem. 276:2001;38044-38051.
46. Wright S. Toll, a new piece in the puzzle of innate immunity. J. Exp. M. 189:1999;605-609.
47. Thiemblemont N., Thieringer R., Wright S. Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement. Immunity. 8:1998;771-777.
48. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:2002;103-110.
49. Bulut Y., Faure E., Thomas L., Equils O., Arditi M. Co-operation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signalling molecules in Toll-like receptor 2 signalling. J. Immunol. 167:2001;987-994.
50. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
51. Fitzgerald K.A., Palsson-McDermot E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., O'Neill L.A. Mal (MyD88-adaptor-like) is required for Toll like receptor 4 signal transduction. Nature. 413:2001;78-83.
52. Horng T., Barton G.M., Medzhitov R. TIRAP, an adaptor molecule in the Toll signalling pathway. Nat. Immunol. 2:2001;835-841.
53. McGee D.J., Rest R.F. Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines. Infect. Immun. 64:1996;4630-4637.
54. Paradis S.E., Dubreuil D., Rioux S., Gottschalk M., Jacques M. High-molecular-mass lipopolysaccharides are involved in Actinobacillus pleuropneumoniae adherence to porcine respiratory tract cells. Infect. Immun. 62:1994;3311-3319.
55. Chan S., Reinhold V.N. Detailed structural characterisation of lipid A: electrospray ionisation coupled with tandem mass spectrometry. Anal. Biochem. 218:1994;63-73.
56. Hansen D.S., Mestre F., Alberti S., Hernandez-Alles S., Alvarez D., Domenech-Sanchez A., Gil J., Merino S., Tomas J.M., Benedi V.J. Klebsiella pneumoniae lipopolysaccharide O-typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries. J. Clin. Microbiol. 37:1999;56-62.
57. Domenico P., Diedrich D.L., Straus D.C. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. Can. J. Microbiol. 31:1985;472-478.
58. Goldberg J.B., Pier G.B. Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. Trends Microbiol. 4:1996;490-494.
59. Salimath P.V., Tharanathan R.N., Weckesser J., Mayer H. The structure of the polysaccharide moiety of Rhodopseudomonas sphaeroides ATCC 17023 lipopolysaccharide. Eur. J. Biochem. 144:1984;227-232.
60. Wilkinson S.G., Galbraith L. Studies of lipopolysaccharides from Pseudomonas aerugionsa. Eur. J. Biochem. 52:1975;331-343.
61. Darveau R.P., Hancock R.E.W. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:1983;831-838.
62. Cryz S., Pitt T.L., Furer E., Germanier R. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect. Immun. 44:1984;508-513.
63. Hancock R.E., Mutharia L.M., Chan L., Darveau R.P., Speert D.P., Pier G.B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42:1983;170-177.
64. Pier G.B., Grout M., Zaidi T.S., Olsen J.C., Johnson L.G., Yankaskas J.R., Goldberg J.B. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 271:1996;64-67.
65. Cryz Jr S.J., Furer E., Cross A.S., Wegmann A., Germanier R., Sadoff J.C. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. J. Clin. Invest. 80:1987;51-60.
66. Cox A.D., Taylor C.J., Anderson A.J., Perry M.B., Wilkinson S.G. Structures of the two polymers present in the lipopolysaccharide of Burkholdaria (Pseudomonas) cepacia serogoup O4. Eur. J. Biochem. 231:1995;784-789.
67. Evans E., Poxton I.R., Govan J.W. Lipopolysaccharide chemotypes of burkholdaria cepacia. J. Med. Microbiol. 48:1999;825-832.
68. Moran A.P., Lindner B., Walsh E.J. Structural characterisation of the lipid A component of Helicobacter pylori rough and smooth form lipopolysaccharides. J. Bacteriol. 179:1997;6453-6463.
69. Monteiro M.A., Chan K.H.N., Rasko D.A., Taylor D.E., Zheng P.Y., Appelmelk B.J., Wirth H., Yang M., Blaser M.J., Hynes S.O., Moran A.P., Perry M.B. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides: molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem. 273:1998;11533-11543.
70. Moran A.P., Walsh E.J. In vitro production of endotoxin by the gastroduodenal pathogen Helicobacter pylori - relevance to serotyping. Ir. J. Med. Sci. 162:1993;384-387.
71. Moran A.P., McGovern J.J., Lindner B., Walsh E.J. Preliminary structural analysis of Helicobacter pylori lipid A. Gut. 37:(Suppl. 1):1995;A16-A18.
72. Lindberg A.A., Weintraub A., Zahringer U., Rietschel E.T. Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev. Infect. Dis. 12:1990;S133-141.
73. Poxton I.R., Edmond D.M. Biological activity of bacteroides lipopolysaccharide - reappraisal. Clin. Infect. Dis. 20:1995;S149-153.
74. Delahooke D., Barclay G., Poxton I. A re-appraisal of the biological activity of bacteroides LPS. Med. Microbiol. 42:1995;102-112.
75. Moran A.P., Prendergast M.M., Appelmelk B.J. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:1996;105-115.
76. Mandrell R.E., Apicella M.A. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host modifications of LOS. Immunobiology. 187:1993;382-402.
77. Hood D.W., Richards J.C., Moxon E.R. Haemophilus influenzae lipopolysaccharide. Biochem. Soc. Trans. 27:1999;493-498.
78. Moxon E.R., Rainey P.B., Nowak M.A., Lenski R.E. Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr. Biol. 4:1994;24-33.
79. Zwahlen A., Rubin L.G., Moxon E.R. Contribution of lipopolysaccharide to pathogenicity of Haemophilus influenzae: comparative virulence of genetically-related strains in rats. Microb. Pathogen. 1:1986;465-473.
80. Flak T.A., Goldman W.E. Signalling and cellular specificity of airway nitric oxide production in pertussis. Cell. Microbiol. 1:1999;51-60.
81. Caroff M., Brisson J.R., Martin A., Karibian D. Structure of the Bordetella pertussis 1414 endotoxin. FEB Lett. 477:2000;8-14.
82. Kosma P. Chlamydial lipopolysaccharide. Biochim. Biophys. Acta. 1455:1999;387-402.